Delivery Order SPE2DB24D2205-SPE2DB25FEHMT
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $8,904.81. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Malarone is an antimalarial medication used for malaria prevention and treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) valued at $1,363.98. This firm fixed-price delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of September 18, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Malarone 250-100 mg tablets in a quantity of 100 units, valued at $1,363.98. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $4,303.64. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Malarone (atovaquone/proguanil) 250/100 mg tablets in a quantity of 100 tablets. This is a firm fixed price delivery order with a ceiling value of $4,549.56 and an ultimate completion date of October 9, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $26,335.89 to AmerisourceBergen Drug Corp for the supply of Malarone 250-100 mg tablets (100-count packages) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Malarone is an antimalarial pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a contract value of $3,182.62. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The order is scheduled for completion by September 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for MALARONE 250/100 antimalarial medication in 100-tablet quantities. The contract is valued at $10,841.78 with firm fixed pricing and an ultimate completion date of September 18, 2025. This is an unset-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The U.S. Defense Medical Supply Chain awarded a $5,859 delivery order to AmerisourceBergen Drug Corp for Malarone 250/100 (100 tablets), a pharmaceutical antimalarial medication. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency. The work will be performed at the contractor's corporate office in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) at a contract ceiling value of $1,818.64. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, where...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHMTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $60,590.43. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Malarone is an antimalarial medication commonly used for malaria prevention and treatment in military personnel deployed to endemic regions. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for the Defense Health Agency and broader federal military healthcare systems, supplying an extensive portfolio of pharmaceutical products and medical supplies. The company's competitively awarded contract portfolio with DLA demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 9/12/25 |